Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-to-moderate hypertension

Journal of Hypertension

Volumn 28, Issue 3, 2010, Pages 622-627

  Van Onzenoort, Hein A W ^a   Verberk, Willem J ^b   Kroon, Abraham A ^c,d   Kessels, Alfons G H ^d   Nelemans, Patricia J ^e   Van Der Kuy, Paul Hugo M ^f   Neef, Cees ^d   De Leeuw, Peter W ^c,d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Microlife Corporation   (Taiwan)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f Sittard Geleen Heerlen   (Netherlands)

Author keywords

Adherence; Blood pressure; Compliance; Hypertension; Self blood pressure measurement; Self measurement

Indexed keywords

AMLODIPINE; HYDROCHLOROTHIAZIDE; LISINOPRIL; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; PATIENT COMPLIANCE; PHYSICIAN; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SELF EXAMINATION; UNIVERSITY HOSPITAL;

EID: 77149149073     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328334f36b     Document Type: Article

References (26)

1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353:487-497.
2. Sabate E. Evidence for action. Geneva: World Health Organization; 2003.
3. Mar J, Rodriguez-Artalejo F. Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance? J Hypertens 2001; 19:149-155.
4. Hughes DA, Bagust A, Haycox A, Walley T. The impact of noncompliance on cost-effectiveness of pharmaceuticals: a review of the literature. Health Economics 2001; 10:601-615.
5. Urquhart J. Partial compliance in cardiovascular disease: risk implications. Br J Clin Pract Suppl 1994; 73:2-12.
6. Urquhart J. Patient noncompliance with drug regimens: measurement, clinical correlates, economic impact. Eur Heart J 1996; 17 (Suppl A): 8-15.
7. Carnahan JE, Nugent CA. The effects of self-monitoring by patients on the control of hypertension. Am J Med Sci 1975; 269:69-73.
8. Feldman R, Bacher M, Campbell N, Drover A, Chockalingam A. Adherence to pharmacologic management of hypertension. CanJ Public Health 1998; 89:I16-I18.
9. Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Control Clin Trials 1997; 18:187-203.
10. Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, de la Figuera-Von Wichmann M, Casado-Martinez JJ, Martin-de Pablos L, et al. Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. J Hypertens 2006; 24:169-175.
11. Ashida T, Sugiyama T, Okuno S, Ebihara A, Fujii J. Relationship between home blood pressure measurement and medication compliance and name recognition of antihypertensive drugs. Hypertens Res 2000; 23:21-24.
12. Verberk WJ, Kroon AA, Kessels AG, Dirksen C, Nelemans PJ, Lenders JWM, et al. Home versus Office blood pressure MEasurements: Reduction of Unnecessary treatment study-rationale and study design of the HOMERUS trial. Blood Press 2003; 12:326-333.
13. Verberk WJ, Thien T, Kroon AA, Lenders JW, van Montfrans GA, Smit AJ, de Leeuw PW. Self-measurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trial. Hypertension 2007; 50:1019-1025.
14. O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit 1996; 1:55-61.
15. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261:3273-3277.
16. WHO Collaborating Centre for Drug Statistics Methodology. http:// www.whocc.no/atcddd/. Consulted 3 September 2008.
17. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150:1377-1378.
18. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336:1114-1117.
19. Wetzels GE, Nelemans P, Schouten JS, Prins MH. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens 2004; 22:1849-1855.
20. Brixner DI, Jackson KC 2nd, Sheng X, Nelson RE, Keskinaslan A. Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations. Curr Med Res Opin 2008; 24:2597-2607.
21. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120:713-719.
22. Gerbino PP, ShoheiberO. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am J Health Syst Pharm 2007; 64:1279-1283.
23. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23:697-701.
24. Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens 1996; 9:1-11.
25. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al., European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848.
26. Stergiou GS, Thomopoulou GC, Skeva II, Mountokalakis TD. Home blood pressure normalcy: the Didima study. Am J Hypertens 2000; 13 (6 pt 1): 678-685.